| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 1991 | 13-Cis Retinoic Acid Induces Cellular Differentiation and Durable Remission in Refractory Ki-1 Lymphoma | Chou, C. M.; Cheng, Ann-Lii; Su, I. J.; Wang, C. H.; Chou, C. M.; 鄭安理 | Cancer | | | |
| 2015 | A novel bubble-mixture method to improve dynamic images in carbon dioxide angiography | Chang, Te-I; Kuo, Sung-Hsin; CHIH-YANG CHAN; Cheng, Ann-Lii; Chan, Chih-Yang; SHOEI-SHEN WANG; Su, Shing-Kuan; I-Hui Wu; Wang, Shoei-Shen; Wu, I-Hui; Chang, T.-I.; Chan, C.-Y.; Su, S.-K.; Wang, S.-S.; Wu, I.-H. | Journal of Endovascular Therapy | 5 | 5 | |
| 1994 | An Alternative Method to Overcome Central Venous Portable External Infusion Pump Blockage in Patients Receiving Weekly 24-Hour High-Dose Fluorouracil and Leucovorin | Cheng, Ann-Lii; Yeh, K. H.; 鄭安理 | Journal of Clinical Oncology | | | |
| 1997 | ANGIOIMMUNOBLASTIC LYMPHADENOPATHY WITH DYSPROTEINEMIA--LACK OF A PROGNOSTIC VALUE OF CLEAR CELL MORPHOLOGY | CHANG, HUI-JU; SU, IH-JEN; CHEN, CHI-LONG; CHIANG, I-PING; CHEN, YAO-CHANG; WANG, CHIU-HWA; CHENG, ANN-LII | ONCOLOGY | | | |
| 2021 | Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patients | Chen, I-Chun; Hu, Fu-Chang; CHING-HUNG LIN ; Huang, Shu-Min; Chang, Dwan-Ying; Cheng, Ann-Lii; Lu, Yen-Shen | Breast (Edinburgh, Scotland) | | 0 | |
| 2001 | Anti-Hilicobacter Pylori Therapy in the Treatment of Stage-Ie High Grade Malt Lymphoma of The | LIN, JAW-TOWN; CHENG, ANN-LII; 鄭安理 | JOURNAL OF CLINICAL ONCOLOGY | | | |
| 2013 | Aspirin antagonizes the cytotoxic effect of methotrexate in lung cancer cells | Yan, Kun-Huang; Lee, Liang-Ming; Hsieh, Mao-Chih; Yan, Ming-De; Yao, Chih-Jung; Chang, Pey-Yi; Chen, Tsung-Li; Chang, Hwan-You; Cheng, Ann-Lii; Lai, Gi-Ming; Chuang, Shuang-En | Oncology Reports | 12 | 16 |  |
| 2021 | Association between risk factors, molecular features and CpG island methylator phenotype colorectal cancer among different age groups in a Taiwanese cohort | Chen, Kuo-Hsing; Lin, Liang-In; Yuan, Chang-Tsu; Tseng, Li-Hui; Chao, Yu-Liang; Liang, Yi-Hsin; Liang, Jin-Tung; BEEN-REN LIN ; Cheng, Ann-Lii; Yeh, Kun-Huei | British journal of cancer | | 0 | |
| 2021 | Association between risk factors, molecular features and CpG island methylator phenotype colorectal cancer among different age groups in a Taiwanese cohort | Chen, Kuo-Hsing; LIANG-IN LIN ; Yuan, Chang-Tsu; Tseng, Li-Hui; Chao, Yu-Liang; Liang, Yi-Hsin; Liang, Jin-Tung; Lin, Been-Ren; Cheng, Ann-Lii; Yeh, Kun-Huei | British journal of cancer | | 0 | |
| 2022 | Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinoma | Shao, Yu-Yun; Kuo, Hung-Yang; Jeng, Yung-Ming; YAO-MING WU ; Wang, Hsiu-Po; CHIUN HSU; CHIH-HUNG HSU; Hsu, Hey-Chi; Cheng, Ann-Lii; Lin, Zhong-Zhe | BMC cancer | 0 | 0 | |
| 2013 | The Aurora Kinases Inhibitor VE-465 is a Novel Treatment for Glioblastoma Multiforme | Lee, Pei-Ying; Chen, Chi-Long; Lin, Zhong-Zhe; Cheng, Ann-Lii; Chen, Edmund I-Tsuen; Whang-Peng, Jacqueline; Huang, Chi-Ying F. | Oncology | 9 | 8 | |
| 2012 | AUY922, a heat shock protein 90 inhibitor, plus 5-fluorouracil inhibits tumors synergistically in gastric cancer MKN45 xenograft via down regulation of multiple pivotal growth factor receptors and oncoproteins | Yeh, Kun-Huei; Kao, Chiu-Hua; Fan, Hsun-Fang; Cheng, Chih-Jen; Lin, Yu-Lin; Cheng, Ann-Lii; 鄭安理 | Cancer Res. | 0 | 0 | |
| 2015 | BKM120 and BYL719 (PI3K inhibitors) sensitize estrogen receptor positive breast cancer cells to tamoxifen | Chen, I-Chun; Gao, Ming; Hsiao, Lii-Ping; Huang, Yi-Wen; Yu, Huei-Chieh; Yeh, Ling-Chiun; Cheng, Ann-Lii; Lu, Yen-Shen | Cancer Res. | 0 | 0 | |
| 1985 | BOMES:A Promising Combination Chemotherapy in the Treatment of Central Nervous System Lymphoma | Cheng, Ann-Lii; Uen, W. C.; Tien, H. F.; Wang, C. H.; Chen, Yee-Chun; 鄭安理 | Proceedings:Annual Meeting of the American Society of Clinical Oncology | | | |
| 2012 | Brivanib (BRI) versus Sorafenib (SOR) as First-line Therapy in Patients with Unresectable, Advanced Hepatocellular Carcinoma (HCC): Results from the Phase 3 BRISK-FL Study | Johnson, Phillip; Qin, Shukui; Park, Joong-Won; Poon, Ronnie T.; Raoul, Jean-Luc; Philip, Philip A.; Hsu, Chih-Hung; Hu, Tsung-Hui; Heo, Jeong; Xu, Jianming; Lu, Ligong; Chao, Yee; Boucher, Eveline; Han, Kwang-Hyub; Paik, Seung Woon; Robles-Avina, Jorge; Kudo, Masatoshi; Liu, David; Ezzeddine, Rana; Walters, Ian; Cheng, Ann-Lii | Hepatology | | | |
| 1988 | Cancer and Cancer Treatment in Taiwan | Cheng, Ann-Lii; 鄭安理 | The 5th International Workshop on Cancer Treatment in Asian Countries | | | |
| 2008 | Carbonic Anhydrase Iii Promotes Transformation and Invasion Capability in Hepatoma Cells through Fak Signaling Pathway | HONG, CHIH-CHEN; LIANG, SAN-CHI; YAN, MING-DE; LAI, GI-MING; CHENG, ANN-LII; CHUANG, SHUANG-EN; 鄭安理 | Molecular Carcinogenesis | 27 | 31 | |
| 2015 | Cetuximab Might Be Detrimental to Metastatic Colorectal Cancer Patients with KRAS Codon 12 Mutations | Liang, Yi-Hsin; Lin, Yu-Lin; Liau, Jau-Yu; Tsai, Jia-Huei; Liang, Jin-Tung; Lin, Been-Ren; Hung, Ji-Shiang; Tseng, Li-Hui; Lin, Liang-In; Chang, Yih-Leong; Cheng, Ann-Lii; Yeh, Kun-Huei | Anticancer Res. | | | |
| 1993 | Characteristic Clinico-Pathologic Features of Epstein-Barr Virus-Associated Peripheral T-Cell Lymphoma | Cheng, Ann-Lii; Su, Ih-Jen; Chen, Yao-Chang; 鄭安理 | Cancer | | | |
| 1989 | Characterization and Spectrum of Post-Thymic T Cell Malignancies in Taiwan | Su, I. J.; Cheng, Ann-Lii; Chen, Yee-Chun; Su, I. J.; Wang, C. H.; 鄭安理 | Cancer | | | |
